We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Research Has Potential for Tackling Signs of Aging

By LabMedica International staff writers
Posted on 24 Dec 2014
A new biomedical research development has the potential to help with fighting diseases and conditions associated with aging, as well as in treating disease such as cancer. More...


The research, which has shown potential in clinical samples, was published November 20, 2014, in the scientific journal, Cell Death and Disease. The group of scientists coordinated by Dr. Salvador Macip from the mechanisms of cancer and aging lab and the department of biochemistry at the University of Leicester (UK) conducted the study to look for new approaches to identifying older cells in the body.

This is important because the accumulation of old cells, called “senescent,” in human tissue can contribute to symptoms of aging. However, old cells can also appear as a result of the activation of the internal anticancer processes of the human body. Dr. Macip said, “What we have found is a series of novel markers—a way to detect senescent cells. What is more, we have shown that they can be used to predict increased survival in certain types of cancer. Until now, good protocols to help spot these cells have been sadly lacking. Our research has described new markers located on the surface of the old cells. This makes these markers particularly useful to quickly identify these cells in laboratory and human samples using a range of techniques.”

As a first clinical application of these markers, the researchers discerned that they were present in high numbers in samples from different types of cancer and that this correlated with a better prognosis of the disease. This was especially apparent in breast cancer. Dr. Macip concluded, “These markers could be useful tools not only to study senescent cells in the lab but also they could be developed into diagnostics to help predict survival in cancer patients. Moreover, they could also be used in the future to define strategies to selectively eliminate the old cells from the tissues and thus reduce their effects on promoting aging in healthy subjects.”

Related Links:

University of Leicester



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.